Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05787821 · ClinicalTrials.gov registry record
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
A clinical trial of Rheumatoid Arthritis and Osteoarthritis, Knee, sponsored by Zimmer Biomet.
- Recruiting
- Registry status
- 760
- Enrollment target
- 16
- Study locations
NCT05787821: Recruiting study of Rheumatoid Arthritis and Osteoarthritis, Knee, sponsored by Zimmer Biomet.
NCT05787821 is a study of Rheumatoid Arthritis and Osteoarthritis, Knee that is actively recruiting participants, run by Zimmer Biomet. The registered enrollment target is 760 participants, below the 4,687-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (84% lower). The trial reports 16 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05787821, a study of Rheumatoid Arthritis and Osteoarthritis, Knee, is actively recruiting participants, sponsored by Zimmer Biomet.
- RECRUITING
- Registry status
- 760 participants
- Enrollment target
- 16
- Study locations
Study Summary
The main objective of the study is to evaluate the safety, performance and clinical benefits of the Persona implant and its instrumentation in primary total knee arthroplasty
Primary Outcome
A patient reported functional outcome score for knee arthroplasty. This score ranges from 0-48, with higher scores indicating a better outcome.
Conditions Studied
Interventions
- DEVICE Total Knee Arthroplasty
Study Locations (16)
New York
- Syracuse Orthopaedic Specialists - DeWitt
- NYU - New York
- St. Francis Hospital & Heart Center - Roslyn
North Carolina
- OrthoCarolina Research Institute, Inc. - Charlotte
- Duke University - Morrisville
Colorado
- Denver Hip & Knee, Inc. - Parker
Florida
- Foundation for Orthopaedic Research & Education - Tampa
Georgia
- Northside Hospital, Inc. - Atlanta
Kentucky
- U of L Health - Louisville
Michigan
- University of Michigan - Ann Arbor
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 760 participants |
| Start Date | 2023-06-28 |
| Est. Completion | 2035-06 |
What NCT05787821 shows while recruiting
NCT05787821 is an observational study that tracks outcomes without assigning an intervention. The registered 760 participants enrollment target is mid-sized for trials with a published cap, below the 4,687-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (84% lower).
The record links to 9 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Total Knee Arthroplasty is the first listed.
NCT05787821 lists 16 locations in 13 states (New York, North Carolina, Colorado).
Frequently Asked Questions
What is clinical trial NCT05787821 about?
NCT05787821 is a clinical study titled "Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)". The main objective of the study is to evaluate the safety, performance and clinical benefits of the Persona implant and its instrumentation in primary total knee arthroplasty
What is the current status of trial NCT05787821?
This trial is currently recruiting. The enrollment target is 760 participants. The study started on 2023-06-28. Estimated completion is 2035-06.
What conditions does trial NCT05787821 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Knee, Avascular Necrosis, Knee Pain Chronic, Traumatic Arthritis.
What interventions are being tested in trial NCT05787821?
The interventions under investigation include: Total Knee Arthroplasty (DEVICE).
Who is sponsoring clinical trial NCT05787821?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05787821 being conducted?
This trial has 16 study locations across Colorado, Florida, Georgia, Kentucky, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05787821's enrollment target sits among peer trials
760 29th of 197 higher than 169 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02089607 · 760 participants · NA
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
- NCT04073706 · 760 participants · Phase 3
Sentinel Node Biopsy in Endometrial Cancer
- NCT05129228 · 760 participants · NA
Optical Coherence Tomography of the Saphenous Vein Graft
- NCT06295367 · 760 participants · NA
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI